← Back to headlines
Biogen Receives FDA Approval for Higher Dose of Genetic Disorder Drug
Biogen has secured approval from the FDA for a higher dosage of its drug designed to treat a genetic disorder.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
